Resumen de acción MVP
Medical Developments International Limited fabrica y distribuye soluciones médicas de emergencia en Australia, Europa, Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Medical Developments International Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.47 |
| 52 Week High | AU$1.80 |
| 52 Week Low | AU$0.42 |
| Beta | 1.61 |
| 1 Month Change | -23.58% |
| 3 Month Change | -46.29% |
| 1 Year Change | -48.35% |
| 3 Year Change | -91.58% |
| 5 Year Change | -90.77% |
| Change since IPO | -2.08% |
Noticias y actualizaciones recientes
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge
Mar 11
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward
Jan 16Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?
Jan 03Recent updates
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge
Mar 11Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward
Jan 16Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?
Jan 03Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Aug 09We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate
Apr 24Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Jul 04Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates
Mar 04Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates
Mar 05If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns
Feb 07Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)
Dec 16Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 10
Rentabilidad de los accionistas
| MVP | AU Pharmaceuticals | Mercado AU | |
|---|---|---|---|
| 7D | -13.0% | 5.2% | -1.3% |
| 1Y | -48.4% | 39.1% | 6.0% |
Rentabilidad vs. Industria: MVP obtuvo unos resultados inferiores a los del sector Australian Pharmaceuticals , que el año pasado arrojó un rendimiento del 27.2%.
Rentabilidad vs. Mercado: MVP obtuvo unos resultados inferiores a los del mercado Australian, que fue del 5.6% el año pasado.
Volatilidad de los precios
| MVP volatility | |
|---|---|
| MVP Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Precio estable de las acciones: El precio de las acciones de MVP ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de MVP (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1971 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited fabrica y distribuye soluciones médicas de emergencia en Australia, Europa, Estados Unidos y a escala internacional. La empresa opera a través de los segmentos de Tratamiento del dolor y Respiratorio. Ofrece dispositivos respiratorios para enfermos de asma y enfermedad pulmonar obstructiva crónica (EPOC); y Penthrox, un producto para el alivio del dolor en traumatismos y urgencias; y dispositivos médicos.
Resumen de fundamentos de Medical Developments International Limited
| Estadísticas fundamentales de MVP | |
|---|---|
| Capitalización bursátil | AU$40.56m |
| Beneficios(TTM) | -AU$19.21m |
| Ingresos (TTM) | AU$33.55m |
1.2x
Ratio precio-ventas (PS)-2.1x
Ratio precio-beneficio (PE)¿Está MVP sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MVP | |
|---|---|
| Ingresos | AU$33.55m |
| Coste de los ingresos | AU$10.17m |
| Beneficio bruto | AU$23.38m |
| Otros gastos | AU$42.59m |
| Beneficios | -AU$19.21m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.22 |
| Margen bruto | 69.69% |
| Margen de beneficio neto | -57.27% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado MVP a largo plazo?
Ver rendimiento histórico y comparativa